Zhang Qiao, Ma Lu, Liu Yi, He Min, Sun Hong, Wang Xiang, Fang Yuan, Hui Xu-hui, You Chao
BMC Neurol. 2013 Aug 19;13:108. doi: 10.1186/1471-2377-13-108.
Subarachnoid hemorrhage is a common and dangerous disease with an unfavorable prognosis. Patients with poor-grade subarachnoid hemorrhage (Hunt & Hess Grades 4-5) are unconscious on admission. Because of the high mortality and disability rate associated with poor-grade subarachnoid hemorrhage, it is often treated conservatively. Timing of surgery for poor-grade aneurysmal subarachnoid hemorrhage is still controversial, therefore this study aims to identify the optimal time to operate on patients admitted in poor clinical condition.
METHODS/DESIGN: Ninety-nine patients meeting the inclusion criteria were randomly assigned into three treatment groups. The early surgery group received operation within 3 days after onset of subarachnoid hemorrhage (day of SAH = day 1); the intermediate surgery group received operation from days 4 to 7, and surgery was performed on the late surgery group after day 7. Follow-up was performed 1, 3, and 6 months after aneurysm clipping. Primary indicators of outcome included the Extended Glasgow Outcome Scale and the Modified Rankin Scale, while secondary indicators of outcome were assessed using the Barthel Index and mortality.
This is the first prospective, single-center, observer-blinded, randomized controlled trial to elucidate optimal timing for surgery in poor-grade subarachnoid hemorrhage patients. The results of this study will be used to direct decisions of surgical intervention in poor-grade subarachnoid hemorrhage, thus improving clinical outcomes for patients.
Chinese Clinical Trial Registry: ChiCTR-TRC-12002917.
蛛网膜下腔出血是一种常见且危险的疾病,预后不佳。低分级蛛网膜下腔出血(Hunt & Hess分级4 - 5级)患者入院时昏迷。由于低分级蛛网膜下腔出血的高死亡率和致残率,通常采用保守治疗。低分级动脉瘤性蛛网膜下腔出血的手术时机仍存在争议,因此本研究旨在确定临床状况较差的入院患者的最佳手术时间。
方法/设计:99名符合纳入标准的患者被随机分为三个治疗组。早期手术组在蛛网膜下腔出血发病后3天内接受手术(蛛网膜下腔出血日 = 第1天);中期手术组在第4至7天接受手术,晚期手术组在第7天后进行手术。在动脉瘤夹闭术后1、3和6个月进行随访。主要结局指标包括扩展格拉斯哥预后量表和改良Rankin量表,次要结局指标使用Barthel指数和死亡率进行评估。
这是第一项前瞻性、单中心、观察者盲法、随机对照试验,旨在阐明低分级蛛网膜下腔出血患者的最佳手术时机。本研究结果将用于指导低分级蛛网膜下腔出血手术干预的决策,从而改善患者的临床结局。
中国临床试验注册中心:ChiCTR - TRC - 12002917。